Bevacizumab Delays Disease Progression in Ovarian Cancer

vitaloptions has 475 videos Subscribe Here

Description: Dr. Tim Perren, MD, discusses the ICON7 showing bevacizumab (Avastin) to standard chemotherapy appears to delay the progression of ovarian cancer, according to data presented here at the 35th European Society for Medical Oncology Congress. (Part 1 of 2)
Shared By : vitaloptions
Posted on : 11/08/10
Added : 9 years ago
Category : Ovarian Cancer

Tags: EMMO 2010

More From vitaloptions

Nothing found.